Herantis Pharma Oyj (HLSE: HRTIS)
Health Care · Pharmaceuticals · FI
€1.42
+1.29% today · -43.5% 1Y
Herantis Pharma Oyj (HLSE: HRTIS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.30M and employs 14 people.
Over the last twelve months the share price has lost 43.5%, trading between 1.34 and 3.87.
Tweenvest scores Herantis Pharma Oyj across four factors: quality 31/100, value 53/100. Its strongest factor is value.
HRTIS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.30M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.27
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- €3.87
- 52-week low
- €1.34
- Avg volume (3M)
- —
- Shares outstanding
- 26.50M
- Employees
- 14
- Next earnings
- —
About Herantis Pharma Oyj
Herantis Pharma Oyj, a biotechnology company founded in Espoo, Finland, in 2008, is dedicated to developing innovative, disease-modifying CDNF-based treatments for Parkinson's disease (PD). Its pipeline features two key assets: HER-096, an advanced small, synthetic chemical peptidomimetic (a modified version of the active CDNF parent molecule) which is in preclinical stages as an xCDNF candidate for Parkinson's and other neurodegenerative conditions; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein currently in Phase I clinical trials for patients with PD.
- ISIN
- FI4000087861
- Founded
- 2008
- Listed since
- Jun 11, 2014
- Exchange
- OMX Nordic Exchange Helsinki
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hayat Pharmaceutical Industries Co. PLCASE: HPIC | $42.77M | JD3.19 | +1.27% |
| Orion Infusion LimitedDSE: ORIONINFU | $42.63M | Tk257.70 | -1.98% |
| Jenburkt Pharmaceuticals LimitedBSE: 524731 | $42.42M | Rs925.40 | -2.43% |
| Neurothera Labs Inc.TSXV: NTLX | $42.38M | CA$4.40 | +0.23% |
| ADBiotech Co., Ltd.KOSDAQ: A179530 | $41.12M | ₩2,055.00 | +17.16% |
| Tsubota Laboratory IncorporatedTSE: 4890 | $41.05M | ¥251.00 | -2.33% |
| InnoPharmax Inc.TPEX: 4172 | $39.98M | NT$10.65 | -0.47% |
| Incannex Healthcare Inc.NasdaqCM: IXHL | $39.89M | $3.20 | +0.63% |
Figures last refreshed Oct 4, 2026.